AstraZeneca Hong Kong Ltd - Company Review
AstraZeneca Hong Kong Ltd - Company ReviewSummary
AstraZeneca Hong Kong Ltd (AstraZeneca), a subsidiary of AstraZeneca Plc is a biopharmaceutical company that offers research and development services. The company discovers, develops and commercializes prescription medicines for healthcare and other market. Its products include arimidex, crestor, cubicin, faslodex, flumist, iressa, meronem, and nexium, among others. astrazeneca provides onglyza, plendil, seroquel, symbicort, vannair, and zinforo. The company offers its products for use in the therapeutic areas of infection, neuroscience, oncology, cardiovascular, gastrointestinal, and respiratory and inflammation. It operates through research and development sites located in Sweden, the UK and the US. AstraZeneca is headquartered in Hong Kong.
This comprehensive company report of AstraZeneca Hong Kong Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.